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Abstract
Re-exposure to drug-related cues elicits drug-seeking behaviour and relapse in humans even after months
of abstinence. Similarly, in laboratory rats, drug-associated stimuli reinstate cocaine seeking after
prolonged withdrawal periods, thus providing a model to study mechanisms underlying cocaine relapse.
5-HT6 receptors (5-HT6Rs) are abundantly expressed in brain areas such as the nucleus accumbens and
prefrontal cortex, which are critically involved in cocaine reinforcement and relapse. Nevertheless, the role
of 5-HT6Rs in relapse mechanisms has not been investigated. We report here that the 5-HT6R antagonists
SB-271046 and Ro-04-6790 signiﬁcantly attenuate cue-induced cocaine seeking. However, eﬀective doses
of both 5-HT6R antagonists did not aﬀect cocaine self-administration. This indicates that 5-HT6Rs are
speciﬁcally involved in the secondary reinforcing properties of cocaine, leaving primary reinforcement
and ability to perform an operant response unaﬀected. As such, 5-HT6Rs may represent a novel target for
the prevention of relapse to cocaine seeking.
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Introduction
In abstinent cocaine users, the propensity to relapse is
high and the eﬀectiveness of therapeutic interventions
even after successful detoxiﬁcation is rather limited.
Therefore, a major focus of drug addiction research is
the identiﬁcation of novel therapeutic targets for drug
development. There is accumulating evidence that the
serotonin (5-hydroxytryptamine, 5-HT) system plays
a modulator role in cocaine addiction (Dhonnchadha
& Cunningham, 2008; Homberg et al. 2008). However,
the underlying mechanisms and the role of speciﬁc
5-HT receptors are not fully understood.
In the past decade, the 5-HT6 receptor (5-HT6R)
has come into focus as a novel target for treatment
of various diseases. Evidence for a role of 5-HT6R in
addiction-related processes is limited, but emerging.
For instance, pharmacological blockade of 5-HT6Rs
was found to enhance amphetamine-induced loco-
motor activity and amphetamine self-administration,
while leaving cocaine-mediated behaviour unaﬀected
(Frantz et al. 2002). More recently, overexpression of
5-HT6Rs in the nucleus accumbens by viral-mediated
gene transfer resulted in reduced place preference
conditioning whereas pharmacological blockade of
5-HT6Rs enhanced place preference conditioning to
cocaine. However, these manipulations did not aﬀect
cocaine-induced stereotypy (Ferguson et al. 2008).
Together, these studies suggest that 5-HT6Rs may play
a role in associative learning processes triggered by
cocaine, but not in the pharmacological eﬀects of the
drug per se. Indeed, there is growing evidence for a
critical role of 5-HT6Rs inmemory formation (Meneses,
2001 ; Rogers & Hagan, 2001).
Associative learning processes play an important
role in the initiation and persistence of cocaine seek-
ing. Re-exposure to drug-associated cues can provoke
drug craving and subsequent relapse to drug use even
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after prolonged abstinence periods (Childress et al.
1988). In the present study we set out to investigate
the role of 5-HT6Rs in cue-induced reinstatement of
cocaine seeking, in a so-called ‘reinstatement model’
(De Vries et al. 2001 ; Epstein et al. 2006). Rats were
pretreated with two chemically distinct 5-HT6R an-
tagonists and tested for relapse behaviour induced
by stimuli previously associated with cocaine deliv-
ery. In addition the eﬀect of these manipulations on
cocaine self-administration was evaluated.
Material and methods
Male Wistar rats (weighing 250–300 g, Harlan, The
Netherlands) were used. The animals were housed in-
dividually in a temperature- and humidity-controlled
room on a reversed 12-h light/dark cycle (lights oﬀ
07:00 hours) with food and water available ad libitum.
Experimental procedures were approved by the Ani-
mal Welfare Committee (VU University, Amsterdam,
The Netherlands) and were performed in accordance
with the recommendations and policies of the United
States National Institutes of Health Principles of Lab-
oratory Animal Care (Clark et al. 1996).
Behavioural procedures and surgery were as pre-
viously described (De Vries et al. 2001). In brief, intra-
venous (i.v.) silicon catheters were implanted in the
right jugular vein under isoﬂurane (1.5–2.0%) anaes-
thesia. Lidocain and adrenalin were used for local
anaesthesia during the surgery. After surgery, animal
received Ketofen (5 mg/kg s.c.) and Baytril (1.25%,
0.2 ml s.c.). Animals were allowed to recover from
surgery for 5–7 d before training started. All training
and testing was conducted in 16 Plexiglas operant
chambers surrounded by sound-attenuating venti-
lated cubicles (TSE Systems, Germany). The chambers
were ﬁtted with a grid ﬂoor, a dim red houselight and
a wall with two nose-poke holes. A red stimulus light
was located above both the nose-poke holes and a
yellow stimulus light within the holes.
One nose-poke hole served as the active hole and
the other as the inactive hole. Pokes made in the active
hole resulted in a delivery of a 40 ml cocaine solution
(0.5 mg/kg per infusion, i.v.) for 2 s. During cocaine
delivery, the active nose-poke hole was illuminated
for 2 s and the houselight and red stimulus light were
switched oﬀ for 15 s. In this time-out period, nose-
poking was without consequences. During the whole
session, pokes in the inactive hole were monitored, but
were without consequences.
Animals were trained on a ﬁxed-ratio 1 schedule
(FR1 schedule) for 10 daily sessions (every active
response resulted in a reward, except in time-out
periods ; sessions were for 60 min). The maximum
number of infusions was set at 50. When responding
was stable (<10% variation during three consecutive
sessions), the extinction period was started. In this
3-wk period (15 daily sessions of 60 min), animals
were placed in the operant chambers, were not con-
nected to the swivel, and cocaine and cocaine-related
stimuli (discrete and discriminative cues) were not
available.
After extinction, the animals were tested for cue-
induced reinstatement (session duration 30 min).
Here, the experimental conditions were similar to the
conditions during training on a FR1 schedule, with
the exception that active responses did not result in a
cocaine infusion – only the presentation of cues.
The animals were tested twice for cue-induced re-
instatement : once with one of the doses of the tested
compound and once with vehicle, in random order.
Between these two test days there was a 7-d period of
further extinction training and wash-out. Treatment
groups were balanced by nose-poke responses dur-
ing the last two cocaine self-administration sessions.
SB-271046 (5-chloro-N-(4-methoxy-3-piperazin-1-
ylphenyl)-3-methyl-2-benzothiophenesulfonamide)
and Ro-04-6790 [(4-amino-N-(2,6-bis-methylamino-
pyramidin-4-yl)-benzene sulphonamide] were syn-
thesized at Abbott. Both compounds were suspended
in 0.5% hydroxypropyl methylcellulose in water and
injected i.p. 30 min before the test, 0 mg/kg (vehicle),
1, 3 and 10 mg/kg (SB-271046) and 3, 10 and 30 mg/kg
(Ro-04-6790).
In the cocaine self-administration tests, each com-
pound was intraperitoneally injected 30 min before
the test. The test lasted 60 min, during which time the
animals could self-administer cocaine (0.5 mg/kg per
infusion) on a FR1 schedule of reinforcement. The
dose range of 5-HT6R antagonist tested was similar
to the range used for the reinstatement tests. The test
design was a latin squares, hence each animal (n=9)
received each dose. Between the test days were 2 or
3 d during which cocaine self-administration was
maintained.
A mixed-factor repeated-measures ANOVA, was
used for analysis of the reinstatement data with drug
dose as the between factor and drug treatment (vehicle
or drug) as the within factor. Further post-hoc testing
was done by pairwise comparisons using a paired
t test. The homogeneity of variance across groups
was determined using Levene’s test of equality of
error variances. In case of violation of homogeneity, a
square-root transformation of the data was performed.
A Kruskal–Wallis test (non-parametric K-independent-
samples test), followed by a Mann–Whitney test was
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used when there was no homogeneity after square-
root transformation.
Results
Cue-induced reinstatement of cocaine seeking
A mixed-factor repeated-measures analysis of the
eﬀects of SB-271046 on nose-pokes made in the active
(previous cocaine-paired) hole revealed a signiﬁcant
eﬀect of drug treatment (F1,27=38.193, p<0.001), a sig-
niﬁcant drugrdose interaction (F2,27=7.757, p=0.002)
and a signiﬁcant eﬀect of dose (F2,27=8.425, p=0.001).
Post-hoc testing showed that SB-271046 signiﬁcantly
reduced nose-pokes made in the active hole at 3 (p=
0.01) and 10 mg/kg (p<0.001; paired t test, Fig. 1a).
Moreover nose-pokes made in the inactive holes were
signiﬁcantly aﬀected by treatment (x2=13.911, Mann–
Whitney test, p=0.003). SB-271046 attenuated inactive
nose-pokes made at 10 mg/kg (p<0.01).
Analysis of the eﬀects of Ro-04-6790 on active
nose-pokes during the relapse test revealed a signiﬁ-
cant eﬀect of drug treatment (F1,24=11.95, p=0.002;
Fig. 1b), no drugrdose interaction and no eﬀect of
dose. Ro-04-6790 did not aﬀect the number of inactive
nose-pokes.
Analysis of the time-course of the eﬀects of both
antagonists on cue-induced reinstatement revealed
that the inhibitory eﬀects on active nose-poke re-
sponding were observed during the ﬁrst 5 min of the
relapse tests (data not shown).
Cocaine self-administration
SB-271046 did not aﬀect the number of rewards
received (F3,24=1.594, p=0.217) or nose-pokes made
in the inactive hole (F3,24=1.360, p=0.281) or total
number of nose-pokes made in the active hole
(F3,24=2.747, p=0.115; Fig. 2a). Ro-04-6790 also did
not aﬀect cocaine self-administration : number of
rewards (F3,21=1.055, p=0.389), inactive nose-pokes
(F3,21=1.427, p=0.271) and total number of active
nose-pokes (F3,21=1.363, p=0.288; Fig. 2b).
Discussion
This is the ﬁrst demonstration that 5-HT6Rs are
involved in the long-term neuronal processes under-
lying relapse to cocaine seeking. The 5-HT6R antago-
nists SB-271046 and Ro-04-6790 dose-dependently
attenuated cue-induced reinstatement of cocaine
seeking in animals with a history of cocaine self-
administration. However, both of the 5-HT6R antag-
onists did not aﬀect responding for cocaine itself.
This indicates that 5-HT6R antagonists selectively
interfere with the reinforcing properties of cocaine-
associated stimuli, but notwith the primary reinforcing
eﬀects of cocaine or with general operant behaviour.
Time-course analysis revealed that both antagonists
suppressed responding for the cocaine cues immedi-
ately at the start of the session, indicating that 5-HT6R
blockade does not facilitate extinction learning, but
rather reduces the impact of cocaine-associated cues.
Since cocaine-associated cues are a major trigger for
relapse to cocaine seeking, blockade of the 5-HT6Rs
may represent a promising novel pharmacological
intervention strategy for the treatment of cocaine
addiction.
SB-271046 and Ro-04-6790 did not aﬀect respond-
ing for a 0.5 mg/kg dose of cocaine at doses that
attenuate cue-induced cocaine seeking, nor have these
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Fig. 1. (a) SB-271046 (n=10) dose-dependently reduced cue-induced reinstatement of cocaine seeking. The highest
does decreased responding on the inactive nose-poke hole. (b) The Ro-04-6790 compound (n=9) also signiﬁcantly reduced
cue-induced reinstatement of cocaine seeking. No eﬀect of treatment on inactive nose-poke responding was found.
* p<0.05, ** p<0.01, *** p<0.001 compared to vehicle.&, Active nose-pokes ;%, inactive nose-pokes.
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compounds been reported to induce pro-cognitive
eﬀects (e.g. King et al. 2004) or reduce spontaneous
locomotor activity (Van Gaalen & Relo, unpublished
results). This lack of eﬀect of 5-HT6R blockade on
cocaine self-administration conﬁrms an earlier report
using SB-258510A (Frantz et al. 2002). Recently, the
5-HT6R antagonist Ro-4368554 was found to facilitate
conditioned place preference to cocaine, but did
not aﬀect cocaine-induced stereotypy (Ferguson et al.
2008). Facilitation of conditioned place preference,
an associative spatial learning task, by 5-HT6R block-
ade may therefore reﬂect a role of 5HT6Rs in spatial
learning and memory, independent of the pharmaco-
logical properties of cocaine. This view is supported
by observations showing that 5-HT6R antagonists
enhance retention of a water maze task (Rogers &
Hagan, 2001).
The molecular mechanisms underlying the relapse-
attenuating eﬀects of 5-HT6R antagonists remain
unclear. 5-HT6R mRNA is highly expressed in the
striatum, nucleus accumbens, olfactory tubercles,
hippocampus and cortex (Monsma et al. 1993 ; Ward
et al. 1995), brain areas that are involved in cognitive
functioning and reward-related behaviour. 5-HT6R
messenger RNA is mainly localized in 5-HT projection
ﬁelds rather than regions of 5-HT containing cell
bodies (Ward et al. 1995). In the hippocampus and
striatum, no eﬀect on 5-HT6R mRNA levels were
found after a lesion with the serotonergic neurotoxin
5,7-DHT, indicating that 5-HT6Rs are located post-
synaptic to serotonergic neurons and do not function
as autoreceptors (Gerard et al. 1996). This is in line
with results from microdialysis studies in which it
was demonstrated that SB-271046 does not aﬀect 5-HT
concentrations in the prefrontal cortex (Dawson et al.
2001 ; Lacroix et al. 2004). Dopamine and noradrena-
line release in the frontal cortex have been reported
to be enhanced after application of 5-HT6R antagonists
in the frontal cortex by some (Lacroix et al. 2004) but
not by others (Dawson et al. 2001 ; Frantz et al. 2002).
Furthermore, 5-HT6R antagonists increase acetyl-
choline and glutamate release in the frontal cortex, but
not in the striatum, nucleus accumbens or hippocam-
pus (Dawson et al. 2001 ; Marcos et al. 2006 ; Riemer
et al. 2003). Such increase in excitatory neurotrans-
mission in the prefrontal cortex may be of particular
relevance to the observed relapse-attenuating eﬀects.
Glutamatergic projections from prefrontal areas to
the ventral striatum are known to play a key role in
reinstatement of drug seeking induced by various
stimuli, including drug-associated cues. (Kalivas &
McFarland, 2003). We have shown recently that re-
exposure to heroin-associated stimuli resulted in an
acute decrease in AMPA receptor functioning in the
ventral part of the medial prefrontal cortex (Van den
Oever et al. 2008). The resulting loss of inhibitory
control over drug seeking could be rescued by re-
storing AMPA receptor functioning. Similarly, but
still speculative, enhancement of excitatory trans-
mission in the prefrontal regions by 5-HT6R antag-
onists may strengthen corticostriatal projections and
allow a better control over drug-seeking behaviour.
However, the eﬀect of 5-HT6R antagonism on the re-
inforcing eﬀects of cocaine and amphetamine appears
to be divergent. Therefore, studying reinstatement
of drug seeking in animals with a history of self-
administration of other classes of drugs of abuse are
required to determine whether 5-HT6R antagonism
is speciﬁcally involved in the secondary reinforcing
properties of cocaine.
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